Daousi, Christina

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors

Daousi, C., Casson, I. F., Gill, G. V., MacFarlane, I. A., Wilding, J. P. H., & Pinkney, J. H. (2006) · Postgraduate Medical Journal

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 351

Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients

Daniel, E., Aylwin, S., Mustafa, O., Ball, S., Munir, A., Boelaert, K., Chortis, V., Cuthbertson, D. J., Daousi, C., Rajeev, S. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 231

Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Cuthbertson, D. J., Irwin, A., Gardner, C. J., Daousi, C., Purewal, T., Furlong, N., Goenka, N., Thomas, E. L., Adams, V. L., Pushpakom, S. P., et al. (2012) · PLoS ONE

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 226

Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response

Thondam, S. K., Daousi, C., Wilding, J. P. H., Holst, J. J., Ameen, G. I., Yang, C., Whitmore, C., Mora, S., & Cuthbertson, D. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 71

GH deficiency after traumatic brain injury: Improvement in quality of life with GH therapy: Analysis of the KIMS database

Gardner, C. J., Mattsson, A. F., Daousi, C., Korbonits, M., Koltowska-Haggstrom, M., & Cuthbertson, D. J. (2015) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 65